This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer APIs. This report contains market size and forecasts of Platinum-based Anticancer APIs in global, including the following market information:
Global Platinum-based Anticancer APIs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Platinum-based Anticancer APIs Market Sales, 2018-2023, 2024-2029, (Kiloton)
Global top five Platinum-based Anticancer APIs companies in 2022 (%)
The global Platinum-based Anticancer APIs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Cisplatin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Platinum-based Anticancer APIs include Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Qilu Pharmaceutical, Neptunus, Hisun, Jiangsu HaiCi biological pharmaceutical, Kunming Guiyan Pharmaceutical, Lingnan Pharmacy and Jinzhou Jiutai Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Platinum-based Anticancer APIs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Platinum-based Anticancer APIs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Platinum-based Anticancer APIs Market Segment Percentages, by Type, 2022 (%)
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Global Platinum-based Anticancer APIs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Platinum-based Anticancer APIs Market Segment Percentages, by Application, 2022 (%)
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Global Platinum-based Anticancer APIs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kiloton)
Global Platinum-based Anticancer APIs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platinum-based Anticancer APIs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Platinum-based Anticancer APIs revenues share in global market, 2022 (%)
Key companies Platinum-based Anticancer APIs sales in global market, 2018-2023 (Estimated), (Kiloton)
Key companies Platinum-based Anticancer APIs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
Outline of Major Chapters:
Chapter 1: Introduces the definition of Platinum-based Anticancer APIs, market overview.
Chapter 2: Global Platinum-based Anticancer APIs market size in revenue and volume.
Chapter 3: Detailed analysis of Platinum-based Anticancer APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Platinum-based Anticancer APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Platinum-based Anticancer APIs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Platinum-based Anticancer APIs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Platinum-based Anticancer APIs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Platinum-based Anticancer APIs Overall Market Size
2.1 Global Platinum-based Anticancer APIs Market Size: 2022 VS 2029
2.2 Global Platinum-based Anticancer APIs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Platinum-based Anticancer APIs Sales: 2018-2029
3 Company Landscape
3.1 Top Platinum-based Anticancer APIs Players in Global Market
3.2 Top Global Platinum-based Anticancer APIs Companies Ranked by Revenue
3.3 Global Platinum-based Anticancer APIs Revenue by Companies
3.4 Global Platinum-based Anticancer APIs Sales by Companies
3.5 Global Platinum-based Anticancer APIs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Platinum-based Anticancer APIs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Platinum-based Anticancer APIs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Platinum-based Anticancer APIs Players in Global Market
3.8.1 List of Global Tier 1 Platinum-based Anticancer APIs Companies
3.8.2 List of Global Tier 2 and Tier 3 Platinum-based Anticancer APIs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Platinum-based Anticancer APIs Market Size Markets, 2022 & 2029
4.1.2 Cisplatin
4.1.3 Carboplatin
4.1.4 Oxaliplatin
4.1.5 Nedaplatin
4.1.6 Others
4.2 By Type - Global Platinum-based Anticancer APIs Revenue & Forecasts
4.2.1 By Type - Global Platinum-based Anticancer APIs Revenue, 2018-2023
4.2.2 By Type - Global Platinum-based Anticancer APIs Revenue, 2024-2029
4.2.3 By Type - Global Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
4.3 By Type - Global Platinum-based Anticancer APIs Sales & Forecasts
4.3.1 By Type - Global Platinum-based Anticancer APIs Sales, 2018-2023
4.3.2 By Type - Global Platinum-based Anticancer APIs Sales, 2024-2029
4.3.3 By Type - Global Platinum-based Anticancer APIs Sales Market Share, 2018-2029
4.4 By Type - Global Platinum-based Anticancer APIs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Platinum-based Anticancer APIs Market Size, 2022 & 2029
5.1.2 Testicular Cancer
5.1.3 Osteosarcoma
5.1.4 Breast Cancer
5.1.5 Esophageal Cancer
5.1.6 NSCLC
5.1.7 Other
5.2 By Application - Global Platinum-based Anticancer APIs Revenue & Forecasts
5.2.1 By Application - Global Platinum-based Anticancer APIs Revenue, 2018-2023
5.2.2 By Application - Global Platinum-based Anticancer APIs Revenue, 2024-2029
5.2.3 By Application - Global Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
5.3 By Application - Global Platinum-based Anticancer APIs Sales & Forecasts
5.3.1 By Application - Global Platinum-based Anticancer APIs Sales, 2018-2023
5.3.2 By Application - Global Platinum-based Anticancer APIs Sales, 2024-2029
5.3.3 By Application - Global Platinum-based Anticancer APIs Sales Market Share, 2018-2029
5.4 By Application - Global Platinum-based Anticancer APIs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Platinum-based Anticancer APIs Market Size, 2022 & 2029
6.2 By Region - Global Platinum-based Anticancer APIs Revenue & Forecasts
6.2.1 By Region - Global Platinum-based Anticancer APIs Revenue, 2018-2023
6.2.2 By Region - Global Platinum-based Anticancer APIs Revenue, 2024-2029
6.2.3 By Region - Global Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
6.3 By Region - Global Platinum-based Anticancer APIs Sales & Forecasts
6.3.1 By Region - Global Platinum-based Anticancer APIs Sales, 2018-2023
6.3.2 By Region - Global Platinum-based Anticancer APIs Sales, 2024-2029
6.3.3 By Region - Global Platinum-based Anticancer APIs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Platinum-based Anticancer APIs Revenue, 2018-2029
6.4.2 By Country - North America Platinum-based Anticancer APIs Sales, 2018-2029
6.4.3 US Platinum-based Anticancer APIs Market Size, 2018-2029
6.4.4 Canada Platinum-based Anticancer APIs Market Size, 2018-2029
6.4.5 Mexico Platinum-based Anticancer APIs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Platinum-based Anticancer APIs Revenue, 2018-2029
6.5.2 By Country - Europe Platinum-based Anticancer APIs Sales, 2018-2029
6.5.3 Germany Platinum-based Anticancer APIs Market Size, 2018-2029
6.5.4 France Platinum-based Anticancer APIs Market Size, 2018-2029
6.5.5 U.K. Platinum-based Anticancer APIs Market Size, 2018-2029
6.5.6 Italy Platinum-based Anticancer APIs Market Size, 2018-2029
6.5.7 Russia Platinum-based Anticancer APIs Market Size, 2018-2029
6.5.8 Nordic Countries Platinum-based Anticancer APIs Market Size, 2018-2029
6.5.9 Benelux Platinum-based Anticancer APIs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Platinum-based Anticancer APIs Revenue, 2018-2029
6.6.2 By Region - Asia Platinum-based Anticancer APIs Sales, 2018-2029
6.6.3 China Platinum-based Anticancer APIs Market Size, 2018-2029
6.6.4 Japan Platinum-based Anticancer APIs Market Size, 2018-2029
6.6.5 South Korea Platinum-based Anticancer APIs Market Size, 2018-2029
6.6.6 Southeast Asia Platinum-based Anticancer APIs Market Size, 2018-2029
6.6.7 India Platinum-based Anticancer APIs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Platinum-based Anticancer APIs Revenue, 2018-2029
6.7.2 By Country - South America Platinum-based Anticancer APIs Sales, 2018-2029
6.7.3 Brazil Platinum-based Anticancer APIs Market Size, 2018-2029
6.7.4 Argentina Platinum-based Anticancer APIs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Platinum-based Anticancer APIs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Platinum-based Anticancer APIs Sales, 2018-2029
6.8.3 Turkey Platinum-based Anticancer APIs Market Size, 2018-2029
6.8.4 Israel Platinum-based Anticancer APIs Market Size, 2018-2029
6.8.5 Saudi Arabia Platinum-based Anticancer APIs Market Size, 2018-2029
6.8.6 UAE Platinum-based Anticancer APIs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Jiangsu Hengrui Medicine
7.1.1 Jiangsu Hengrui Medicine Company Summary
7.1.2 Jiangsu Hengrui Medicine Business Overview
7.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Major Product Offerings
7.1.4 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.1.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.2 Nanjing Pharmaceutical Factory
7.2.1 Nanjing Pharmaceutical Factory Company Summary
7.2.2 Nanjing Pharmaceutical Factory Business Overview
7.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Major Product Offerings
7.2.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.2.5 Nanjing Pharmaceutical Factory Key News & Latest Developments
7.3 Qilu Pharmaceutical
7.3.1 Qilu Pharmaceutical Company Summary
7.3.2 Qilu Pharmaceutical Business Overview
7.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Major Product Offerings
7.3.4 Qilu Pharmaceutical Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.3.5 Qilu Pharmaceutical Key News & Latest Developments
7.4 Neptunus
7.4.1 Neptunus Company Summary
7.4.2 Neptunus Business Overview
7.4.3 Neptunus Platinum-based Anticancer APIs Major Product Offerings
7.4.4 Neptunus Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.4.5 Neptunus Key News & Latest Developments
7.5 Hisun
7.5.1 Hisun Company Summary
7.5.2 Hisun Business Overview
7.5.3 Hisun Platinum-based Anticancer APIs Major Product Offerings
7.5.4 Hisun Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.5.5 Hisun Key News & Latest Developments
7.6 Jiangsu HaiCi biological pharmaceutical
7.6.1 Jiangsu HaiCi biological pharmaceutical Company Summary
7.6.2 Jiangsu HaiCi biological pharmaceutical Business Overview
7.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Major Product Offerings
7.6.4 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.6.5 Jiangsu HaiCi biological pharmaceutical Key News & Latest Developments
7.7 Kunming Guiyan Pharmaceutical
7.7.1 Kunming Guiyan Pharmaceutical Company Summary
7.7.2 Kunming Guiyan Pharmaceutical Business Overview
7.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Major Product Offerings
7.7.4 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.7.5 Kunming Guiyan Pharmaceutical Key News & Latest Developments
7.8 Lingnan Pharmacy
7.8.1 Lingnan Pharmacy Company Summary
7.8.2 Lingnan Pharmacy Business Overview
7.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Major Product Offerings
7.8.4 Lingnan Pharmacy Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.8.5 Lingnan Pharmacy Key News & Latest Developments
7.9 Jinzhou Jiutai Pharmaceutical
7.9.1 Jinzhou Jiutai Pharmaceutical Company Summary
7.9.2 Jinzhou Jiutai Pharmaceutical Business Overview
7.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Major Product Offerings
7.9.4 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.9.5 Jinzhou Jiutai Pharmaceutical Key News & Latest Developments
7.10 Nanjing Hairun Pharmaceutical
7.10.1 Nanjing Hairun Pharmaceutical Company Summary
7.10.2 Nanjing Hairun Pharmaceutical Business Overview
7.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Major Product Offerings
7.10.4 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.10.5 Nanjing Hairun Pharmaceutical Key News & Latest Developments
7.11 Simcere
7.11.1 Simcere Company Summary
7.11.2 Simcere Platinum-based Anticancer APIs Business Overview
7.11.3 Simcere Platinum-based Anticancer APIs Major Product Offerings
7.11.4 Simcere Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.11.5 Simcere Key News & Latest Developments
7.12 Teva
7.12.1 Teva Company Summary
7.12.2 Teva Platinum-based Anticancer APIs Business Overview
7.12.3 Teva Platinum-based Anticancer APIs Major Product Offerings
7.12.4 Teva Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.12.5 Teva Key News & Latest Developments
7.13 Cipla
7.13.1 Cipla Company Summary
7.13.2 Cipla Platinum-based Anticancer APIs Business Overview
7.13.3 Cipla Platinum-based Anticancer APIs Major Product Offerings
7.13.4 Cipla Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.13.5 Cipla Key News & Latest Developments
7.14 Heraeus
7.14.1 Heraeus Company Summary
7.14.2 Heraeus Business Overview
7.14.3 Heraeus Platinum-based Anticancer APIs Major Product Offerings
7.14.4 Heraeus Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.14.5 Heraeus Key News & Latest Developments
7.15 Hospira(Pfizer)
7.15.1 Hospira(Pfizer) Company Summary
7.15.2 Hospira(Pfizer) Business Overview
7.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Major Product Offerings
7.15.4 Hospira(Pfizer) Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.15.5 Hospira(Pfizer) Key News & Latest Developments
7.16 Taj Pharmaceuticals
7.16.1 Taj Pharmaceuticals Company Summary
7.16.2 Taj Pharmaceuticals Business Overview
7.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Major Product Offerings
7.16.4 Taj Pharmaceuticals Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.16.5 Taj Pharmaceuticals Key News & Latest Developments
7.17 Umicore Precious Metals Chemistry
7.17.1 Umicore Precious Metals Chemistry Company Summary
7.17.2 Umicore Precious Metals Chemistry Business Overview
7.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Major Product Offerings
7.17.4 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales and Revenue in Global (2018-2023)
7.17.5 Umicore Precious Metals Chemistry Key News & Latest Developments
8 Global Platinum-based Anticancer APIs Production Capacity, Analysis
8.1 Global Platinum-based Anticancer APIs Production Capacity, 2018-2029
8.2 Platinum-based Anticancer APIs Production Capacity of Key Manufacturers in Global Market
8.3 Global Platinum-based Anticancer APIs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Platinum-based Anticancer APIs Supply Chain Analysis
10.1 Platinum-based Anticancer APIs Industry Value Chain
10.2 Platinum-based Anticancer APIs Upstream Market
10.3 Platinum-based Anticancer APIs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Platinum-based Anticancer APIs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Platinum-based Anticancer APIs in Global Market
Table 2. Top Platinum-based Anticancer APIs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Platinum-based Anticancer APIs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Platinum-based Anticancer APIs Revenue Share by Companies, 2018-2023
Table 5. Global Platinum-based Anticancer APIs Sales by Companies, (Kiloton), 2018-2023
Table 6. Global Platinum-based Anticancer APIs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Platinum-based Anticancer APIs Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Platinum-based Anticancer APIs Product Type
Table 9. List of Global Tier 1 Platinum-based Anticancer APIs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Platinum-based Anticancer APIs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Platinum-based Anticancer APIs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Platinum-based Anticancer APIs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Platinum-based Anticancer APIs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Platinum-based Anticancer APIs Sales (Kiloton), 2018-2023
Table 15. By Type - Global Platinum-based Anticancer APIs Sales (Kiloton), 2024-2029
Table 16. By Application ? Global Platinum-based Anticancer APIs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Platinum-based Anticancer APIs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Platinum-based Anticancer APIs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Platinum-based Anticancer APIs Sales (Kiloton), 2018-2023
Table 20. By Application - Global Platinum-based Anticancer APIs Sales (Kiloton), 2024-2029
Table 21. By Region ? Global Platinum-based Anticancer APIs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Platinum-based Anticancer APIs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Platinum-based Anticancer APIs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Platinum-based Anticancer APIs Sales (Kiloton), 2018-2023
Table 25. By Region - Global Platinum-based Anticancer APIs Sales (Kiloton), 2024-2029
Table 26. By Country - North America Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Platinum-based Anticancer APIs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Platinum-based Anticancer APIs Sales, (Kiloton), 2018-2023
Table 29. By Country - North America Platinum-based Anticancer APIs Sales, (Kiloton), 2024-2029
Table 30. By Country - Europe Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Platinum-based Anticancer APIs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Platinum-based Anticancer APIs Sales, (Kiloton), 2018-2023
Table 33. By Country - Europe Platinum-based Anticancer APIs Sales, (Kiloton), 2024-2029
Table 34. By Region - Asia Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Platinum-based Anticancer APIs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Platinum-based Anticancer APIs Sales, (Kiloton), 2018-2023
Table 37. By Region - Asia Platinum-based Anticancer APIs Sales, (Kiloton), 2024-2029
Table 38. By Country - South America Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Platinum-based Anticancer APIs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Platinum-based Anticancer APIs Sales, (Kiloton), 2018-2023
Table 41. By Country - South America Platinum-based Anticancer APIs Sales, (Kiloton), 2024-2029
Table 42. By Country - Middle East & Africa Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Platinum-based Anticancer APIs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Platinum-based Anticancer APIs Sales, (Kiloton), 2018-2023
Table 45. By Country - Middle East & Africa Platinum-based Anticancer APIs Sales, (Kiloton), 2024-2029
Table 46. Jiangsu Hengrui Medicine Company Summary
Table 47. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Offerings
Table 48. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 50. Nanjing Pharmaceutical Factory Company Summary
Table 51. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Offerings
Table 52. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Nanjing Pharmaceutical Factory Key News & Latest Developments
Table 54. Qilu Pharmaceutical Company Summary
Table 55. Qilu Pharmaceutical Platinum-based Anticancer APIs Product Offerings
Table 56. Qilu Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Qilu Pharmaceutical Key News & Latest Developments
Table 58. Neptunus Company Summary
Table 59. Neptunus Platinum-based Anticancer APIs Product Offerings
Table 60. Neptunus Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Neptunus Key News & Latest Developments
Table 62. Hisun Company Summary
Table 63. Hisun Platinum-based Anticancer APIs Product Offerings
Table 64. Hisun Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. Hisun Key News & Latest Developments
Table 66. Jiangsu HaiCi biological pharmaceutical Company Summary
Table 67. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Offerings
Table 68. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Jiangsu HaiCi biological pharmaceutical Key News & Latest Developments
Table 70. Kunming Guiyan Pharmaceutical Company Summary
Table 71. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Offerings
Table 72. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Kunming Guiyan Pharmaceutical Key News & Latest Developments
Table 74. Lingnan Pharmacy Company Summary
Table 75. Lingnan Pharmacy Platinum-based Anticancer APIs Product Offerings
Table 76. Lingnan Pharmacy Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Lingnan Pharmacy Key News & Latest Developments
Table 78. Jinzhou Jiutai Pharmaceutical Company Summary
Table 79. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Offerings
Table 80. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. Jinzhou Jiutai Pharmaceutical Key News & Latest Developments
Table 82. Nanjing Hairun Pharmaceutical Company Summary
Table 83. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Offerings
Table 84. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. Nanjing Hairun Pharmaceutical Key News & Latest Developments
Table 86. Simcere Company Summary
Table 87. Simcere Platinum-based Anticancer APIs Product Offerings
Table 88. Simcere Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. Simcere Key News & Latest Developments
Table 90. Teva Company Summary
Table 91. Teva Platinum-based Anticancer APIs Product Offerings
Table 92. Teva Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 93. Teva Key News & Latest Developments
Table 94. Cipla Company Summary
Table 95. Cipla Platinum-based Anticancer APIs Product Offerings
Table 96. Cipla Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 97. Cipla Key News & Latest Developments
Table 98. Heraeus Company Summary
Table 99. Heraeus Platinum-based Anticancer APIs Product Offerings
Table 100. Heraeus Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 101. Heraeus Key News & Latest Developments
Table 102. Hospira(Pfizer) Company Summary
Table 103. Hospira(Pfizer) Platinum-based Anticancer APIs Product Offerings
Table 104. Hospira(Pfizer) Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 105. Hospira(Pfizer) Key News & Latest Developments
Table 106. Taj Pharmaceuticals Company Summary
Table 107. Taj Pharmaceuticals Platinum-based Anticancer APIs Product Offerings
Table 108. Taj Pharmaceuticals Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 109. Taj Pharmaceuticals Key News & Latest Developments
Table 110. Umicore Precious Metals Chemistry Company Summary
Table 111. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Offerings
Table 112. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 113. Umicore Precious Metals Chemistry Key News & Latest Developments
Table 114. Platinum-based Anticancer APIs Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2021-2023 (Kiloton)
Table 115. Global Platinum-based Anticancer APIs Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Platinum-based Anticancer APIs Production by Region, 2018-2023 (Kiloton)
Table 117. Global Platinum-based Anticancer APIs Production by Region, 2024-2029 (Kiloton)
Table 118. Platinum-based Anticancer APIs Market Opportunities & Trends in Global Market
Table 119. Platinum-based Anticancer APIs Market Drivers in Global Market
Table 120. Platinum-based Anticancer APIs Market Restraints in Global Market
Table 121. Platinum-based Anticancer APIs Raw Materials
Table 122. Platinum-based Anticancer APIs Raw Materials Suppliers in Global Market
Table 123. Typical Platinum-based Anticancer APIs Downstream
Table 124. Platinum-based Anticancer APIs Downstream Clients in Global Market
Table 125. Platinum-based Anticancer APIs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Platinum-based Anticancer APIs Segment by Type in 2022
Figure 2. Platinum-based Anticancer APIs Segment by Application in 2022
Figure 3. Global Platinum-based Anticancer APIs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Platinum-based Anticancer APIs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Platinum-based Anticancer APIs Revenue, 2018-2029 (US$, Mn)
Figure 7. Platinum-based Anticancer APIs Sales in Global Market: 2018-2029 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Platinum-based Anticancer APIs Revenue in 2022
Figure 9. By Type - Global Platinum-based Anticancer APIs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 12. By Type - Global Platinum-based Anticancer APIs Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Platinum-based Anticancer APIs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 16. By Application - Global Platinum-based Anticancer APIs Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Platinum-based Anticancer APIs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Platinum-based Anticancer APIs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 21. By Country - North America Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 23. US Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 28. Germany Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 29. France Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 37. China Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 41. India Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 44. Brazil Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Platinum-based Anticancer APIs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Platinum-based Anticancer APIs Sales Market Share, 2018-2029
Figure 48. Turkey Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Platinum-based Anticancer APIs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Platinum-based Anticancer APIs Production Capacity (Kiloton), 2018-2029
Figure 53. The Percentage of Production Platinum-based Anticancer APIs by Region, 2022 VS 2029
Figure 54. Platinum-based Anticancer APIs Industry Value Chain
Figure 55. Marketing Channels
